GSK Prepares For Malaria Vaccine Roll-Out In Africa By 2015

“While we have seen some decline in vaccine efficacy over time, the sheer number of children affected by malaria means that the number of cases of the disease the vaccine can help prevent is impressive,” GSK CEO Witty says.